The growing burden of chronic obstructive pulmonary disease and other respiratory diseases which further causes mucociliary dysfunction, propels the market growth worldwide. Increased adoption of effective treatment for the mucociliary clearance results in tremendous growth of market within the forecast period. Moreover, the continuous surge in respiratory disease is anticipated to result in growth of the mucociliary clearance and dysfunction treatment market at a notable rate over the coming years.
